- Home
- MOMO vs MDXG Comparison
MOMO vs MDXG Comparison
Compare MOMO & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOMO
- MDXG
- Stock Information
- Founded
- MOMO 2011
- MDXG 2006
- Country
- MOMO China
- MDXG United States
- Employees
- MOMO N/A
- MDXG N/A
- Industry
- MOMO Computer Software: Prepackaged Software
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- MOMO Technology
- MDXG Health Care
- Exchange
- MOMO Nasdaq
- MDXG Nasdaq
- Market Cap
- MOMO 909.4M
- MDXG 877.4M
- IPO Year
- MOMO 2014
- MDXG N/A
- Fundamental
- Price
- MOMO $8.96
- MDXG $6.41
- Analyst Decision
- MOMO Buy
- MDXG Strong Buy
- Analyst Count
- MOMO 2
- MDXG 2
- Target Price
- MOMO $10.00
- MDXG $11.50
- AVG Volume (30 Days)
- MOMO 1.3M
- MDXG 921.3K
- Earning Date
- MOMO 09-02-2025
- MDXG 07-30-2025
- Dividend Yield
- MOMO 3.37%
- MDXG N/A
- EPS Growth
- MOMO N/A
- MDXG N/A
- EPS
- MOMO 1.06
- MDXG 0.27
- Revenue
- MOMO $1,450,201,337.00
- MDXG $352,375,000.00
- Revenue This Year
- MOMO $1.42
- MDXG $9.55
- Revenue Next Year
- MOMO $4.17
- MDXG $11.43
- P/E Ratio
- MOMO $8.48
- MDXG $24.89
- Revenue Growth
- MOMO N/A
- MDXG 5.34
- 52 Week Low
- MOMO $5.12
- MDXG $5.47
- 52 Week High
- MOMO $9.22
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- MOMO 68.44
- MDXG 56.56
- Support Level
- MOMO $8.71
- MDXG $6.00
- Resistance Level
- MOMO $9.12
- MDXG $6.87
- Average True Range (ATR)
- MOMO 0.22
- MDXG 0.31
- MACD
- MOMO -0.03
- MDXG 0.05
- Stochastic Oscillator
- MOMO 83.51
- MDXG 72.52
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.